Pathways found to be enriched included Type I diabetes, Allograft rejection, Steroid hormone biosynthesis, Ferroptosis, Arginine/proline metabolism, Base excision repair, Long-term potentiation/depression, and Intestinal IgA production (Fig. 1E). This evidence concerns the gene CD79A and type 1 diabetes mellitus.